US gastrointestinal (GI) and rare diseases specialist has announced financial guidance for full year 2026, which pleased ...

US biotech Corcept Therapeutics (Nasdaq: CORT) said the American medicines regulator has issued a complete response letter ...

US pharma major Pfizer (NYSE: PFE) has reported the death of a participant enrolled in a long-term extension study of its ...

US biotech Ultragenyx Pharmaceutical In this week revealed that it has completed the rolling submission of its Biologics ...

China-based Insilico Medicine, an AI-driven drug discovery and a portfolio company of Qiming Venture Partners, has ...

China’s Zelgen Pharma has entered into a strategic collaboration and license option agreement with US pharma major AbbVie for ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has today approved Kostaive (zapomeran) mRNA COVID-19 ...

The US Food and Drug Administration (FDA) has accepted for filing Axsome Therapeutics’ supplemental New Drug Application (NDA ...

German drug discovery company Evotec (Nasdaq: EVO) has announced the appointment of Dr Sarah Fakih as executive vice ...

South Korean biosimilar specialist Samsung Bioepis today announced that it has begun direct commercialization of Byooviz, a biosimilar to Lucentis (ranibizumab), in Europe.

US biopharma company Greenwich LifeSciences has announced an 80% reduction in breast cancer recurrence from its ongoing Phase ...

Indian pharma major Lupin Limited announced that it has entered into an exclusive license, supply and distribution agreement ...